When regulatory expectations change by the phase, the route can be difficult and confusing to navigate for both new and experienced potency investigators.
- Global Implications Of Zero Tariffs On Indian Pharma Exports To China
- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
- Process Validation: Working Toward Harmonization Of Terms Used To Identify Validation Lots
- Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development
- What Can The Tech Sector's 'Minimally Viable' Concept Teach Biopharma?
- What Biotech Sponsors Should Look For In A CDMO For Sterile Fill/Finish
- New Group Wants 'Phase-Appropriate' Thinking To Retire
- Inside Arbor Biotech's In Vivo Gene Therapy Approach
ON-DEMAND WEBINARS
In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.
This webinar will offer best practices for UAT for sponsor organizations with the aim of changing the conversations and expectations around the UAT process.
Individual data points over time can provide precise drug dosing histories that enable better understanding of protocol adherence, safety, efficacy, PK/PD and a drug’s exposure-response relationship.
Discover how flexible, site-focused monitoring strategies are transforming clinical trials by improving communication, enhancing compliance, and resolving challenges before they impact study success.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1214763114 Medical Research Scientist Working In Laboratory]( "Top Clinical Research Themes And Trends")
Top Clinical Research Themes And TrendsWe analyzed web traffic, content downloads, social media engagement, webinar attendance, and other metrics to determine the themes that caught your attention and aligned with broader industry trends.
-
![Scientist syringe vaccine GettyImages-1351831059]( "Overcome The Supply Chain Complexities Of Vaccine Development")
Overcome The Supply Chain Complexities Of Vaccine DevelopmentExplore the industry impact of rapidly evolving vaccinology, the power of next-gen science and technology, and how finding the right supply chain partner has never been more essential.
-
![BO 2 - GC_App_^CZ vial with stopper and seal stack up]( "Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization")
Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To CommercializationWhile in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.
-
![GettyImages-1359760465 doctor ipad]( "Unified Platform Supports Rapid Implementation Of Rescue Study")
Unified Platform Supports Rapid Implementation Of Rescue StudyExplore how these integrated solutions helped an emerging biopharma to implement a plan for study build and migration with minimal disruption to sites.
-
![GettyImages-1499160012-patient-paperwork-clipboard-waiting-room-doctor-office]( "5 Tips To Put The Right Systems In Place For Successful Clinical Trials")
5 Tips To Put The Right Systems In Place For Successful Clinical TrialsBefore you dive into clinical trials, ask yourself: Is my company operationally ready to handle the complexity? Learn about key upgrades that can help you streamline operations and reduce risk.
-
![Trial Design]( "When Protocol Amendments Meet RTSM: From Headache To High-Performance")
When Protocol Amendments Meet RTSM: From Headache To High-PerformanceLearn why an RTSM solution should be adaptive and flexible, and should help clinical trial teams uncover the best ways to handle protocol amendments.
-
![GettyImages-1288118586 cell development]( "Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials")
Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical TrialsLearn how the establishment of effective guidelines and standardization relevant to cell therapy development can help to minimize delays and lead to more positive outcomes.
-
![ERP]( "How Pharmaceutical Manufacturers Can Take Control Of Their Supply Chain")
How Pharmaceutical Manufacturers Can Take Control Of Their Supply ChainIn an increasingly competitive and regulated landscape, the right ERP system is no longer optional—it’s essential to reclaim control and drive growth in pharmaceutical manufacturing.
-
![Panademic Related Manufacturing Complications]( "Outsourcers Are Feeling Uneasy About Continuity Of Supply")
Outsourcers Are Feeling Uneasy About Continuity Of SupplyFind out how COVID-19 complications have picked up from the first year, with more outsourcers experiencing bigger obstacles when it comes to manufacturing, specifically with drug product.
-
![IRT Getty 1407865352]( "3 Study Areas Where Your IRT Vendor Should Do More")
3 Study Areas Where Your IRT Vendor Should Do MoreFind out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
